Runze Pharmaceutical Suzhou Co.,Ltd.

Company Description

Runze Parmaceutical (Suzhou) Co.,LTD.,established in June 2003, is a progressive pharmaceutical corporation invested by Shandong Runze & Ruiying Parmaceutical Group.

With an area of 40,000 sq.meters in China-Singapore Suzhou industrial park, the leading industrial park in China, Runze Pharmaceutical Suzhou Co.,Ltd. mainly engaged in develops, manufactures and supply Pharmaceutical intermediates, APIs, and drugs in final dosage forms.

We have advanced R&D centre and very powerful research and developing team composed by American scientist, Ph.D. and post graduates from key domestic pharmaceutical research institute, universities and abroad.
Our parent company is fully integrated; US-FDA approved pharmaceutical company with product focusing on the cephalosporin and penicillin antibiotics.
In December 2008, Runze Pharmaceutical (Suzhou) obtained ISO9001 and OHSAS 18001 certification and in May 2009 passed ISO14001 certification. It has been audited by many customers from multinational corporations, and got GMP certificate in 2013.

Our main products:

Rosuvastatin,Atorvastatin,clopidogrel intermediates,
cephalosporin and penicillin antibiotics
Ursodeoxycholic Acid,L-Carnosine,Cholic Acid,BAPA,Isoprinosine,Ceftiofur hydrochloride,flunixin meglumine.

Friends and clients from home and abroad please feel free to contact us or visit us for business cooperation and we are confident we will meet your requirements for your better development!